News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Noven Pharmaceuticals Inc. (NOVN) Earns Milestone Payment Under P&G Pharmaceuticals, Inc. (PG) Collaboration


10/19/2005 5:10:53 PM

MIAMI--(BUSINESS WIRE)--Dec. 29, 2004--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that it has earned a $3.0 million success fee for attaining a development milestone under its development collaboration with P&G Pharmaceuticals, Inc., a subsidiary of The Procter & Gamble Company. Noven expects to report the $3.0 million success fee as license and contract revenues for the quarter ending December 31, 2004.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES